羟基wybutosine tRNA修饰作为白血病疾病进展的指标和治疗靶点
本研究探讨转运RNA修饰尤其是羟基wybutosine(OHyW)在骨髓增生异常综合征(MDS)向急性髓系白血病(AML)转化中的作用。发现AML较MDS的OHyW及其合成酶LCMT2(TYW4)水平显著降低,AML前体水平升高提示生物合成通路受损。LCMT2低表达与AML细胞系药物敏感性降低和分化潜能受限相关,提示靶向LCMT2可能改善AML治疗结局。
要点
- AML较MDS的OHyW及LCMT2水平显著降低。
- AML中OHyW降低而前体升高,提示生物合成通路受损。
- LCMT2低表达与AML细胞系药物敏感性降低和分化潜能受限相关。
核心结论
- tRNA修饰在MDS向AML进展中起关键作用,靶向LCMT2可能增强AML治疗效果。
研究设计与样本
- 本研究比较了AML与MDS的tRNA修饰,尤其是OHyW及其合成酶LCMT2水平。
主要发现
- AML较MDS的OHyW和LCMT2水平显著降低。
- 质谱分析显示AML中OHyW降低而前体水平升高,提示生物合成通路受损。
- LCMT2低表达与AML细胞系药物敏感性降低和分化潜能受限相关。
临床怎么用
- 作者认为靶向LCMT2可能增强AML治疗效果。
- 作者认为理解这些分子机制可开发新的诊断标志物和治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Therapeutic approaches for acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) differ due to distinct diagnostic criteria and treatment strengths. However, reliable biomarkers to differentiate AML from MDS are needed. This study investigated transfer RNA (tRNA) modifications, particularly hydroxy-wybutosine (OHyW), in the transition from MDS to AML. We found a significant decrease in OHyW and its biosynthetic enzyme leucine carboxyl methyltransferase 2 (LCMT2, alias symbol is TYW4) levels in AML compared to MDS. Mass spectrometric analysis revealed distinct tRNA modification patterns, with AML showing decreased OHyW and increased precursor levels, indicating a disrupted biosynthetic pathway. Lower LCMT2 expression correlated with reduced drug sensitivity and limited differentiation potential in AML cell lines. The results highlight the pivotal role of tRNA modifications in the progression from MDS to AML and suggest that targeting LCMT2 may enhance therapeutic outcomes in AML. By understanding these molecular mechanisms, we can develop new diagnostic markers and therapeutic strategies, potentially transforming the clinical management of AML and improving patient outcomes.
引用
- Chen X, Gong RZ, Mo LY, et al. Hydroxy-wybutosine tRNA modifications as indicators of disease progression and therapeutic targets in leukaemia. Br J Haematol. 2024. PMID: 39523586. doi:10.1111/bjh.19873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。